Veradigm Net Profit Margin 2012-2022 | MDRX
Veradigm net profit margin from 2012 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Veradigm Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2022-12-31 | $0.59B | $-0.09B | -14.60% |
| 2022-09-30 | $0.60B | $0.07B | 10.93% |
| 2022-06-30 | $0.60B | $0.07B | 11.22% |
| 2022-03-31 | $0.59B | $0.15B | 26.06% |
| 2021-12-31 | $0.58B | $0.14B | 24.05% |
| 2021-09-30 | $-0.14B | $0.77B | -550.00% |
| 2021-06-30 | $0.08B | $0.76B | 932.10% |
| 2021-03-31 | $0.31B | $0.73B | 234.63% |
| 2020-12-31 | $0.56B | $0.70B | 125.18% |
| 2020-09-30 | $1.43B | $-0.05B | -3.22% |
| 2020-06-30 | $1.51B | $-0.05B | -3.52% |
| 2020-03-31 | $1.58B | $-0.20B | -12.33% |
| 2019-12-31 | $1.63B | $-0.18B | -11.21% |
| 2019-09-30 | $1.63B | $0.21B | 12.94% |
| 2019-06-30 | $1.62B | $0.18B | 11.19% |
| 2019-03-31 | $1.62B | $0.40B | 24.52% |
| 2018-12-31 | $1.62B | $0.36B | 22.51% |
| 2018-09-30 | $1.52B | $0.00B | -0.33% |
| 2018-06-30 | $1.53B | $0.00B | 0.13% |
| 2018-03-31 | $1.52B | $-0.22B | -14.30% |
| 2017-12-31 | $1.50B | $-0.20B | -13.16% |
| 2017-09-30 | $1.55B | $-0.21B | -13.55% |
| 2017-06-30 | $1.49B | $-0.19B | -12.79% |
| 2017-03-31 | $1.45B | $-0.05B | -3.23% |
| 2016-12-31 | $1.39B | $-0.03B | -1.80% |
| 2016-09-30 | $1.47B | $0.00B | -0.14% |
| 2016-06-30 | $1.43B | $0.00B | 0.21% |
| 2016-03-31 | $1.40B | $0.01B | 0.72% |
| 2015-12-31 | $1.39B | $0.00B | -0.14% |
| 2015-09-30 | $1.38B | $-0.02B | -1.45% |
| 2015-06-30 | $1.37B | $-0.04B | -2.99% |
| 2015-03-31 | $1.37B | $-0.06B | -4.08% |
| 2014-12-31 | $1.38B | $-0.07B | -4.87% |
| 2014-09-30 | $1.39B | $-0.09B | -6.20% |
| 2014-06-30 | $1.37B | $-0.11B | -7.94% |
| 2014-03-31 | $1.37B | $-0.11B | -8.35% |
| 2013-12-31 | $1.37B | $-0.11B | -7.65% |
| 2013-09-30 | $1.37B | $-0.11B | -7.87% |
| 2013-06-30 | $1.40B | $-0.05B | -3.56% |
| 2013-03-31 | $1.43B | $-0.02B | -1.33% |
| 2012-12-31 | $1.45B | $0.00B | -0.07% |
| 2012-09-30 | $1.48B | $0.05B | 3.30% |
| 2012-06-30 | $1.49B | $0.06B | 3.97% |
| 2012-03-31 | $1.47B | $0.07B | 4.55% |
| 2011-12-31 | $1.44B | $0.07B | 5.12% |
| 2011-09-30 | $1.37B | $0.04B | 3.06% |
| 2011-06-30 | $1.25B | $0.02B | 1.92% |
| 2011-03-31 | $1.08B | $0.02B | 1.94% |
| 2010-09-30 | $0.62B | $0.03B | 5.35% |
| 2010-06-30 | $0.56B | $0.05B | 9.01% |
| 2010-03-31 | $0.53B | $0.05B | 9.94% |
| 2010-02-28 | $0.51B | $0.05B | 9.14% |
| 2009-09-30 | $0.49B | $0.04B | 7.94% |
| 2009-08-31 | $0.46B | $0.02B | 4.40% |
| 2009-02-28 | $0.47B | $0.02B | 3.44% |
| 2008-11-30 | $0.39B | $0.01B | 1.30% |
| 2008-08-31 | $0.25B | $0.01B | 2.83% |
| 2008-06-30 | $0.25B | $0.01B | 4.78% |
| 2008-03-31 | $0.31B | $0.02B | 6.75% |
| 2008-02-29 | $0.31B | $0.03B | 8.09% |
| 2007-12-31 | $0.28B | $0.02B | 7.45% |
| 2007-11-30 | $0.38B | $0.00B | 1.06% |
| 2007-09-30 | $0.35B | $0.00B | 0.86% |
| 2007-06-30 | $0.34B | $0.00B | 0.88% |
| 2007-05-31 | $0.33B | 0 | 0.00% |
| 2007-03-31 | $0.25B | $0.01B | 5.58% |
| 2006-12-31 | $0.23B | $0.01B | 4.82% |
| 2006-09-30 | $0.20B | $0.01B | 5.05% |
| 2006-06-30 | $0.17B | $0.01B | 5.99% |
| 2006-03-31 | $0.14B | $0.01B | 6.57% |
| 2005-12-31 | $0.12B | $0.01B | 7.44% |
| 2005-09-30 | $0.11B | $0.01B | 6.19% |
| 2005-06-30 | $0.11B | $0.01B | 4.63% |
| 2005-03-31 | $0.10B | $0.00B | 3.85% |
| 2004-12-31 | $0.10B | $0.00B | 2.97% |
| 2004-09-30 | $0.10B | $0.00B | 2.02% |
| 2004-06-30 | $0.10B | 0 | 0.00% |
| 2004-03-31 | $0.09B | $0.00B | -3.37% |
| 2003-12-31 | $0.09B | $-0.01B | -5.81% |
| 2003-09-30 | $0.08B | $-0.01B | -8.54% |
| 2003-06-30 | $0.08B | $-0.01B | -11.25% |
| 2003-03-31 | $0.08B | $-0.01B | -13.75% |
| 2002-12-31 | $0.08B | $-0.02B | -18.99% |
| 2002-09-30 | $0.08B | $-0.02B | -28.21% |
| 2002-06-30 | $0.07B | $-0.37B | -501.35% |
| 2002-03-31 | $0.07B | $-0.40B | -541.10% |
| 2001-12-31 | $0.07B | $-0.42B | -591.55% |
| 2001-09-30 | $0.07B | $-0.43B | -608.57% |
| 2001-06-30 | $0.07B | $-0.09B | -128.99% |
| 2001-03-31 | $0.06B | $-0.09B | -138.71% |
| 2000-12-31 | $0.06B | $-0.06B | -103.64% |
| 2000-09-30 | $0.05B | $-0.05B | -104.44% |
| 2000-06-30 | $0.04B | $-0.04B | -97.30% |
| 2000-03-31 | $0.03B | $-0.02B | -48.39% |
| 1999-12-31 | $0.03B | $-0.01B | -44.44% |
| 1999-06-30 | $0.02B | $-0.01B | -27.78% |
| 1999-03-31 | $0.02B | $0.00B | -16.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.536B | $0.000B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.549B | 41.11 |
| Tempus AI (TEM) | United States | $11.881B | 0.00 |
| Doximity (DOCS) | United States | $7.738B | 31.86 |
| Hims & Hers Health (HIMS) | United States | $6.936B | 56.43 |
| IRHYTHM HLDGS (IRTC) | United States | $5.335B | 0.00 |
| Hinge Health (HNGE) | United States | $3.276B | 0.00 |
| Heartflow (HTFL) | United States | $2.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.855B | 178.54 |
| 10x Genomics (TXG) | United States | $2.791B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.744B | 45.41 |
| Omnicell (OMCL) | United States | $2.202B | 45.01 |
| Azenta (AZTA) | United States | $1.818B | 74.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.321B | 6.93 |
| Schrodinger (SDGR) | United States | $1.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.043B | 0.00 |
| Phreesia (PHR) | United States | $0.948B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.856B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.471B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.353B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 13.86 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.290B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.156B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.092B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.064B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.039B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |